Uncategorised
We are thrilled to announce the shortlist for this year’s Therapy Provider of the Year Award, sponsored by Irwin Mitchell. This award recognises the exceptional providers leading the way in neurorehabilitation through innovative treatments, compassionate care and dedicated service to patients on their journey to recovery. Each of the shortlisted providers has demonstrated a commitment [...]
Neuro-rehab continues to see huge advances, with new technology and ways of working helping to redefine what is possible for patients with neurological injury or illness. Now, the NR Times team has shortlisted three organisations that have embraced innovation to give new hope and secure beyond-expectation outcomes, helping to create examples of best practice which [...]
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 23 October 2024, approved a licence for the medicine donanemab (Kisunla) for use in the early stages of Alzheimer’s disease, following a thorough review of the benefits and risks. Donanemab works by removing a sticky protein called beta-amyloid from the brain that is believed to [...]
Researchers have shed new light on the way in which air pollution can cause cognitive decline. Fine particulate matter, known as PM2.5, is a complex mixture of many chemicals that can be inhaled deep into the lungs. While PM2.5 exposure has long been linked to tissue damage and inflammation in the lung, its role in [...]
Three charities have been shortlisted for the NR Times Charity of the Year award, sponsored by Burnetts Solicitors. The award recognises those charities whose interventions are so critical to the lives of those living with neurological illness or injury, working in innovative and proactive ways to sustain and grow the organisation, while putting service users [...]
In one of the largest studies of DNA and brain volume, researchers have identified 254 genetic variants that shape key structures in the “deep brain,” including those that control memory, motor skills, addictive behaviours and more. The findings could have implications for the development of treatments and diagnostics for neurological conditions. The study is led [...]
In a study of commonly used treatments for people with multiple sclerosis (MS), both medical and behavioural interventions, and a combination of the two, resulted in meaningful improvements in fatigue. The randomised clinical trial compared the effectiveness of modafinil, a wake-promoting medication used to treat sleepiness in people with sleep disorders, and cognitive behavioural therapy [...]
Severely injured children who are brought to an emergency medical department by their parents or carers are often not seen as quickly as those who arrive at hospital via ambulance, a study in a UK hospital has found. The study, presented this week at the European Emergency Medicine Congress, was carried out in an inner-city [...]
Research funded by the US defence department is aiming to unpick the causes of neuropsychiatric problems associated with Parkinson's. Around half of Parkinson’s patients will experience neuropsychiatric problems, including cognitive and sleep issues, depression, anxiety, even psychosis. A study backed by US$3m from the US Department for Defense is investigating the underlying causes of these [...]
Researchers have received a $29 million NIH grant for The Triangulation of Innovative Methods to End Alzheimer’s Disease project to study dementia risk factors, prevention, and treatment. The project will use large, diverse datasets to examine whether interventions targeting alcohol use, depression, vision or hearing impairments, or social isolation can protect people from Alzheimer’s disease [...]
